Serial #98907246
DEAD

Serial Number

98907246

Owner

Sanguine Biosciences, Inc.

Attorney

Elizabeth Oliner

First Use Date

May 18, 2023

Filing Date

Dec 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98907246 Trademark

Serial Number: 98907246

Serial #98907246 is a trademark filed by Sanguine Biosciences, Inc. on December 17, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Sanguine Biosciences, Inc. (8 trademarks)

400 W Cummings Park, Suite 3050
Woburn, MA 01801

Entity Type: 03

Trademark Details

Filing Date

December 17, 2024

Registration Date

Not Registered

First Use Anywhere

May 18, 2023

First Use in Commerce

May 18, 2023

Goods & Services

Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology related to biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications; Providing an on-line searchable database in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology and health for scientific research purposes; Providing an on-line searchable database in the field of biospecimen and data collection for scientific research purposes; Providing information about medical research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational applications; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Research laboratory analysis services in the field of biospecimens for cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research; Research laboratory analysis services in the field of providing biospecimen analysis, cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research; Scientific laboratory services; Scientific research for medical purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications; Scientific research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, oncology and health research; Providing scientific research information in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications via biospecimen collection and data collection; Providing scientific research information in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications via biospecimen collection and data collection for research purposes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 1, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 1, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 5, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 5, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 5, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 3, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 25, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 25, 2025 NWOS
NEW APPLICATION ENTERED
Dec 17, 2024 NWAP